These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3944194)

  • 1. Serum factors that stimulate fatty acid oxidation: physiological specificity.
    Stanisz J; Wice BM; Kennell DE
    J Cell Physiol; 1986 Jan; 126(1):141-6. PubMed ID: 3944194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative energy metabolism in cultured heart muscle and HeLa cells.
    Stanisz J; Wice BM; Kennell DE
    J Cell Physiol; 1983 Jun; 115(3):320-30. PubMed ID: 6853608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum factors that stimulate fatty acid oxidation: properties of factors.
    Wice BM; Stanisz J; Kennell DE
    J Cell Physiol; 1986 Jan; 126(1):133-40. PubMed ID: 3944193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts.
    Sorokina N; O'Donnell JM; McKinney RD; Pound KM; Woldegiorgis G; LaNoue KF; Ballal K; Taegtmeyer H; Buttrick PM; Lewandowski ED
    Circulation; 2007 Apr; 115(15):2033-41. PubMed ID: 17404155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilization in isolated myocytes.
    Abdel-aleem S; Nada MA; Sayed-Ahmed M; Hendrickson SC; St Louis J; Walthall HP; Lowe JE
    J Mol Cell Cardiol; 1996 May; 28(5):825-33. PubMed ID: 8762022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of non-oxidative glucose utilization by L-carnitine in isolated myocytes.
    Abdel-aleem S; Sayed-Ahmed M; Nada MA; Hendrickson SC; St Louis J; Lowe JE
    J Mol Cell Cardiol; 1995 Nov; 27(11):2465-72. PubMed ID: 8596197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of metabolic flux distributions for MDCK cell growth in glutamine- and pyruvate-containing media.
    Sidorenko Y; Wahl A; Dauner M; Genzel Y; Reichl U
    Biotechnol Prog; 2008; 24(2):311-20. PubMed ID: 18215054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
    Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of glucose and glutamine metabolism in transformed mammalian cell lines, insect and primary liver cells.
    Neermann J; Wagner R
    J Cell Physiol; 1996 Jan; 166(1):152-69. PubMed ID: 8557765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of pyruvate and pyruvate precursors by normal and carcinogen-altered rat tracheal epithelial cells in culture.
    Wasilenko WJ; Marchok AC
    J Cell Physiol; 1986 Jan; 126(1):69-76. PubMed ID: 3944199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats.
    Visarius TM; Stucki JW; Lauterburg BH
    J Pharmacol Exp Ther; 1999 May; 289(2):820-4. PubMed ID: 10215658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes.
    Palanivel R; Fang X; Park M; Eguchi M; Pallan S; De Girolamo S; Liu Y; Wang Y; Xu A; Sweeney G
    Cardiovasc Res; 2007 Jul; 75(1):148-57. PubMed ID: 17499232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of carnitine-dependent metabolic pathways in heart disease without primary ischemia.
    Bremer J; Hokland B
    Z Kardiol; 1987; 76 Suppl 5():9-13. PubMed ID: 3324530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry.
    Law LK; Tang NL; Hui J; Ho CS; Ruiter J; Fok TF; Wanders RJ; Lam CW
    Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy substrate metabolism in fresh and stored human platelets.
    Cohen P; Wittels B
    J Clin Invest; 1970 Jan; 49(1):119-27. PubMed ID: 5409800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: structure-activity relationships.
    Tune BM; Hsu CY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):873-80. PubMed ID: 7932199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation.
    Sipula IJ; Brown NF; Perdomo G
    Metabolism; 2006 Dec; 55(12):1637-44. PubMed ID: 17142137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisystem triglyceride storage disorder with impaired long-chain fatty acid oxidation.
    Angelini C; Philippart M; Borrone C; Bresolin N; Cantini M; Lucke S
    Ann Neurol; 1980 Jan; 7(1):5-10. PubMed ID: 7362208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.